Q9912 (Q9912): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Removed claims)
(‎Changed an Item)
Property / EU contribution
 
3,600,000.0 Czech koruna
Amount3,600,000.0 Czech koruna
UnitCzech koruna
Property / EU contribution: 3,600,000.0 Czech koruna / rank
 
Normal rank
Property / EU contribution
 
144,000.0 Euro
Amount144,000.0 Euro
UnitEuro
Property / EU contribution: 144,000.0 Euro / rank
 
Preferred rank
Property / EU contribution: 144,000.0 Euro / qualifier
 
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
Property / EU contribution: 144,000.0 Euro / qualifier
 
point in time: 10 January 2020
Timestamp+2020-01-10T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / budget
 
8,000,000.0 Czech koruna
Amount8,000,000.0 Czech koruna
UnitCzech koruna
Property / budget: 8,000,000.0 Czech koruna / rank
 
Normal rank
Property / budget
 
320,000.0 Euro
Amount320,000.0 Euro
UnitEuro
Property / budget: 320,000.0 Euro / rank
 
Preferred rank
Property / budget: 320,000.0 Euro / qualifier
 
exchange rate to Euro: 0.04 Euro
Amount0.04 Euro
UnitEuro
Property / budget: 320,000.0 Euro / qualifier
 
point in time: 10 January 2020
Timestamp+2020-01-10T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 16:21, 11 February 2020

Project in Czech Republic financed by DG Regio
Language Label Description Also known as
English
No label defined
Project in Czech Republic financed by DG Regio

    Statements

    0 references
    3,600,000.0 Czech koruna
    0 references
    144,000.0 Euro
    10 January 2020
    0 references
    8,000,000.0 Czech koruna
    0 references
    320,000.0 Euro
    10 January 2020
    0 references
    45 percent
    0 references
    1 March 2017
    0 references
    9 October 2018
    0 references
    31 October 2018
    0 references
    MEDIWARE a.s.
    0 references

    50°5'39.41"N, 14°20'3.98"E
    0 references

    50°6'17.86"N, 14°22'51.35"E
    0 references
    16000
    0 references
    Firma MEDIWARE a.s. vyvinula a provozuje projekt MWPharm sloužící pro optimální návrh farmakoterapie pro humánní medicínu. V poslední době se zvyšuje poptávka (zejména ze zemí SAE) na obdobný projekt, který bude sloužit pro hospodářská zvířata, závodní koně, chovy velbloudů ale i malá zvířata (psy a kočky). Projekt MWPharVet bude tedy inovací projektu MWPharm zaměřený důsledně na veterinární medicínu a bude řešen v úzké spolupráci s fakultou veterinární a farmaceutickou v Brně. (Czech)
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_014/0001982
    0 references